comparemela.com

Latest Breaking News On - Krishnam ella - Page 8 : comparemela.com

Exclusive: Bharat Biotech s Suchitra Ella confident on vaccine production commitments

Bharat Biotech cuts vaccine price for States to ₹400/dose

Maharashtra scouts for 12 cr vax for 18-45 age group

Maharashtra scouts for 12 cr vax for 18-45 age group ​ By IANS | ​ 7 Views Maharashtra scouts for 12 cr vax for 18-45 age group. Image Source: IANS News Mumbai, April 27 : Barely 72 hours before the ambitious phase of vaccination for 18-45 age groups begins from May 1, the Maharashtra government has started scouting around for getting sufficient quantities of the Covid-19 jabs, officials said here on Tuesday. Health Department Principal Secretary Dr Pradeep Vyas has sent separate letters to Serum Institute of India CEO Adar Poonawala and Bharat Biotech International Ltd Chairman and Managing Director Dr Krishna M. Ella to the effect. He said that if the Maharashtra government decides to vaccinate its 18-45 age group population, estimated at around 5-crore, then it would require some 12-crore vaccine doses.

Maharashtra scouts for 12 crore Covid vaccines for 18-45 age group

 0 Barely 72 hours before the ambitious phase of vaccination for 18-45 age groups begins from May 1, the Maharashtra government has started scouting around for getting sufficient quantities of the Covid-19 jabs, officials said here on Tuesday.   Health Department Principal Secretary Dr Pradeep Vyas has sent separate letters to Serum Institute of India CEO Adar Poonawala and Bharat Biotech International Ltd Chairman and Managing Director Dr Krishna M. Ella to the effect.   He said that if the Maharashtra government decides to vaccinate its 18-45 age group population, estimated at around 5-crore, then it would require some 12-crore vaccine doses.   Vyas asked the two how many doses of Covishield (SII) and Covaxin (BBIL) vaccines the two companies could supply to the state government, per month over the next six months from May 2021 onwards.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.